Skin Manifestations of Targeted Antineoplastic Therapy

    November 2017 in “ Current problems in dermatology
    O. Sanmartín
    TLDR Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.
    The document discussed the significant advancements in targeted immunotherapy for treating various inflammatory and malignant skin disorders. It highlighted the improved patient outcomes due to these newer therapies, which are used for both approved and off-label indications. The book provided insights into the safety profiles of these therapies, including adverse reactions, infectious complications, and perioperative use in conditions like psoriasis, autoimmune bullous diseases, and skin cancers. Contributions from eminent researchers offered an in-depth overview of the latest knowledge in the field, aiming to enhance the understanding and management of these therapies to improve patient outcomes.
    Discuss this study in the Community →

    Cited in this study

    2 / 2 results